These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38130842)

  • 1. Which Groups of Children Are at More Risk of Fatality during COVID-19 Pandemic? A Case-Control Study in Yazd, Iran.
    Shafaei B; Nafei Z; Karimi M; Behniafard N; Shamsi F; Faisal M; Amel Shahbaz AP; Akbarian E
    Can J Infect Dis Med Microbiol; 2023; 2023():8838056. PubMed ID: 38130842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcome of Covid-19 illness and predictors of in-hospital mortality in Saudi Arabia.
    Abolfotouh MA; Musattat A; Alanazi M; Alghnam S; Bosaeed M
    BMC Infect Dis; 2022 Dec; 22(1):950. PubMed ID: 36526994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Mortality in Children: A Referral Center Experience from Iran (Mofid Children's Hospital, Tehran, Iran).
    Armin S; Fahimzad SA; Rafiei Tabatabaei S; Mansour Ghanaiee R; Marhamati N; Ahmadizadeh SN; Behzad A; Hashemi SM; Sadr S; Rajabnejad M; Jamee M; Karimi A
    Can J Infect Dis Med Microbiol; 2022; 2022():2737719. PubMed ID: 35340920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and Mortality in Hospitalized Children with COVID-19: A Referral Center Experience in Yazd, Iran.
    Shamsi F; Karimi M; Nafei Z; Akbarian E
    Can J Infect Dis Med Microbiol; 2023; 2023():5205188. PubMed ID: 37492855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: a single-center experience.
    Yu C; Lei Q; Li W; Wang X; Li W; Liu W
    J Infect Public Health; 2020 Sep; 13(9):1202-1209. PubMed ID: 32718894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.
    Bhandari S; Singh A; Sharma R; Rankawat G; Banerjee S; Gupta V; Dube A; Kakkar S; Sharma S; Keswani P; Agrawal A; Tak A; Nawal CL
    J Assoc Physicians India; 2020 Jun; 68(6):13-19. PubMed ID: 32610873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness.
    Rokni M; Ahmadikia K; Asghari S; Mashaei S; Hassanali F
    BMC Infect Dis; 2020 Nov; 20(1):869. PubMed ID: 33225909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of clinical, laboratory and chest CT findings of laboratory-confirmed and clinically diagnosed COVID-19 patients at first admission.
    Kuzan TY; Murzoğlu Altıntoprak K; Çiftçi HÖ; Ergül U; Ünal Özdemir NB; Bulut M; Yiyit N
    Diagn Interv Radiol; 2021 May; 27(3):336-343. PubMed ID: 32876570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medico-demographic characteristics and outcomes of COVID-19 patients admitted to a provincial hospital in Center-West of Morocco.
    Natoubi S; Amgoun R; Baghdad N; Elkhadir MA; Lafaf A; Mouqhach R; Bouazizi A; Maroui I
    Pan Afr Med J; 2022; 42():268. PubMed ID: 36338558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chest HRCT Severity Scores among Hospitalized Patients with COVID-19.
    Paul D; Bhuiya MI; Paul UK; Dey B; Khan MK
    Mymensingh Med J; 2022 Jul; 31(3):819-825. PubMed ID: 35780369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological, clinical, and laboratory findings for patients of different age groups with confirmed coronavirus disease 2019 (COVID-19) in a hospital in Saudi Arabia.
    Ibrahim ME; Al-Aklobi OS; Abomughaid MM; Al-Ghamdi MA
    PLoS One; 2021; 16(4):e0250955. PubMed ID: 33914805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19.
    Zhou S; Chen C; Hu Y; Lv W; Ai T; Xia L
    Ann Transl Med; 2020 Nov; 8(21):1449. PubMed ID: 33313194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
    Alavi Darazam I; Hatami F; Rabiei MM; Pourhoseingholi MA; Moradi O; Shokouhi S; Hajesmaeili MR; Shabani M; Irvani SSN
    Trials; 2020 Oct; 21(1):880. PubMed ID: 33106183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.
    El Aidaoui K; Haoudar A; Khalis M; Kantri A; Ziati J; El Ghanmi A; Bennis G; El Yamani K; Dini N; El Kettani C
    Cureus; 2020 Sep; 12(9):e10716. PubMed ID: 33033687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and laboratory findings and PCR results in severe and non-severe COVID19 patients based on CURB-65 and WHO severity indices.
    Karimi F; Saleh M; Vaezi AA; Qorbani M; Avanaki FA
    Virol J; 2021 Sep; 18(1):189. PubMed ID: 34535175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chest X-ray Findings and Hyponatremia in COVID-19 Pneumonia Patients.
    Habas E; Abugrara Said A; Faidh Ramzee A; Ghazouani H; Fino A; Abu Khattab MA; Al Masalamani MS; Prabhakaran Nair A
    Qatar Med J; 2022; 2022(3):34. PubMed ID: 35974882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.